Product Description
| Species | Rabbits. |
|---|---|
| Composition |
Inactivated rabbit haemorrhagic disease type 2 virus (RHDV2), strain V-1037: ≥70% cELISA40* (*) ≥70 % of vaccinated rabbits shall give cELISA antibody titres equal to or higher than 40.
Whitish emulsion. |
| Indications |
For active immunisation of rabbits from the age of 30 days to reduce mortality caused by the rabbit haemorrhagic disease type 2 virus (RHDV2). Onset of immunity: 1 week. |
| Dosage and method of administration | Subcutaneous use. Administer 1 dose (0.5 ml) of the veterinary medicinal product to rabbits from the age of 30 days by subcutaneous injection in the lateral thoracic wall. Revaccination: 9 months after vaccination |
| Contraindications | Do not use in case of hypersensitivity to the active substance, to the adjuvant or to any of the excipients. |
| Warning |
|
| Release form | Cardboard box of 10 glass vial of 1 dose (0.5 ml). Cardboard box of 1 glass vial of 10 doses (5 ml). Cardboard box of 1 glass vial of 40 doses (20 ml). Not all pack sizes may be marketed. |
| Storage conditions | Store and transport refrigerated (2 ºC – 8 ºC). |
| Shelf life | Shelf life after first opening the immediate packaging: Use immediately. |
Eravac